A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
NCT00412451
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
ocriplasmin
OTHER:
Sham injection
Sponsor
ThromboGenics